Trevarx Biomedical
Philadelphia, US · Founded 2016 · Delaware corporation
Founders & leadership
JC
Jean ChoinExecutive
Reported raises · per SEC filings
Form D private placements$1.5M disclosed across 3 rounds · 2019–2025
▶$350KraisedAug 2025 · 6 investors · BiotechnologyRule 506(b)
▶$350KraisedAug 2025 · 6 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jean ChoExecutive Officer, Director
- Offering amount
- $750K
- Amount sold
- $350K
- First sale
- Jul 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$500KraisedSep 2022 · 10 investors · BiotechnologyRule 506(b)
▶$500KraisedSep 2022 · 10 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jean ChoExecutive Officer, Director
- Offering amount
- $500K
- Amount sold
- $500K
- First sale
- Sep 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$650KraisedAug 2019 · 11 investors · OtherRule 506(b)
▶$650KraisedAug 2019 · 11 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Jean ChoExecutive Officer, Director
- Offering amount
- $850K
- Amount sold
- $650K
- First sale
- Jul 2019
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- How much funding has Trevarx Biomedical raised?
- Trevarx Biomedical has disclosed $1.5M raised across 3 rounds.
- Where is Trevarx Biomedical headquartered?
- Trevarx Biomedical is headquartered in Philadelphia, US.